These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30382954)

  • 1. Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease.
    Karelehto E; Wildenbeest JG; Benschop KSM; Koen G; Rebers S; Bouma-de Jongh S; Westerhuis BM; de Jong MD; Pajkrt D; Wolthers KC
    Pediatr Infect Dis J; 2018 Dec; 37(12):1304-1308. PubMed ID: 30382954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human parechovirus seroprevalence in Finland and the Netherlands.
    Westerhuis B; Kolehmainen P; Benschop K; Nurminen N; Koen G; Koskiniemi M; Simell O; Knip M; Hyöty H; Wolthers K; Tauriainen S
    J Clin Virol; 2013 Sep; 58(1):211-5. PubMed ID: 23891146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis.
    Westerhuis BM; Benschop KS; Koen G; Claassen YB; Wagner K; Bakker AQ; Wolthers KC; Beaumont T
    J Virol; 2015 Aug; 89(15):7457-64. PubMed ID: 25948742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3.
    Aizawa Y; Watanabe K; Oishi T; Hirano H; Hasegawa I; Saitoh A
    Emerg Infect Dis; 2015 Nov; 21(11):1966-72. PubMed ID: 26485714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of severe human parechovirus infections in newborns and infants in Hungary].
    Boros Á; Hamarics Z; Fenyvesi H; Liptai Z; Nyul Z; Pankovics P; Reuter G
    Orv Hetil; 2019 Mar; 160(10):386-395. PubMed ID: 30829060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development.
    Westerhuis BM; Koen G; Wildenbeest JG; Pajkrt D; de Jong MD; Benschop KSM; Wolthers KC
    J Gen Virol; 2012 Nov; 93(Pt 11):2363-2370. PubMed ID: 22837420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014.
    Tanaka S; Aoki Y; Matoba Y; Yahagi K; Itagaki T; Matsuzaki Y; Mizuta K
    Microbiol Immunol; 2016 Dec; 60(12):854-858. PubMed ID: 27925289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human parechovirus infections in Dutch children and the association between serotype and disease severity.
    Benschop KS; Schinkel J; Minnaar RP; Pajkrt D; Spanjerberg L; Kraakman HC; Berkhout B; Zaaijer HL; Beld MG; Wolthers KC
    Clin Infect Dis; 2006 Jan; 42(2):204-10. PubMed ID: 16355330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human parechovirus in Chinese children hospitalized for acute gastroenteritis.
    Zhang DL; Jin Y; Li DD; Cheng WX; Xu ZQ; Yu JM; Jin M; Yang SH; Zhang Q; Cui SX; Liu N; Duan ZJ
    Clin Microbiol Infect; 2011 Oct; 17(10):1563-9. PubMed ID: 21040159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR.
    Westerhuis BM; Jonker SC; Mattao S; Benschop KS; Wolthers KC
    Virol J; 2013 May; 10():146. PubMed ID: 23668373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human parechovirus associated sepsis and central nervous system infections in hospitalized children].
    Luo L; Zhu R; Zhao L; Deng J; Wang F; Sun Y; Song Q; Ding Y; Qian Y
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):444-8. PubMed ID: 25190165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human Parechoviruses].
    Aizawa Y; Saitoh A
    Uirusu; 2015; 65(1):17-26. PubMed ID: 26923954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan.
    Watanabe K; Hirokawa C; Tazawa T
    Epidemiol Infect; 2016 Dec; 144(16):3451-3460. PubMed ID: 27571735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Human Parechovirus Genotypes in Yokohama District from 2000 to 2016.
    Momoki TS
    Jpn J Infect Dis; 2018 Jul; 71(4):298-301. PubMed ID: 29709970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-dependent neutralization reveals antigenic variation of human parechovirus 3.
    Karelehto E; van der Sanden S; Geraets JA; Domanska A; van der Linden L; Hoogendoorn D; Koen G; van Eijk H; Shakeel S; Beaumont T; de Jong M; Pajkrt D; Butcher SJ; Wolthers KC
    Sci Rep; 2017 Sep; 7(1):12075. PubMed ID: 28935894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples.
    Wildenbeest JG; Benschop KS; Minnaar RP; Bouma-de Jongh S; Wolthers KC; Pajkrt D
    Clin Microbiol Infect; 2014 Oct; 20(10):O640-7. PubMed ID: 24438366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of human Parechovirus (HPeV) genotypes in the Amsterdam region and identification of specific HPeV variants by direct genotyping of stool samples.
    Benschop K; Thomas X; Serpenti C; Molenkamp R; Wolthers K
    J Clin Microbiol; 2008 Dec; 46(12):3965-70. PubMed ID: 18945833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of human parechoviruses 4-6 infections in young children.
    Pajkrt D; Benschop KS; Westerhuis B; Molenkamp R; Spanjerberg L; Wolthers KC
    Pediatr Infect Dis J; 2009 Nov; 28(11):1008-10. PubMed ID: 19536040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics-based prediction of conformational epitopes for human parechovirus.
    Rong H; Wang L; Gao L; Fang Y; Chen Q; Hu J; Ye M; Liao Q; Zhang L; Dong C
    PLoS One; 2021; 16(4):e0247423. PubMed ID: 33793559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence, features of circulation, and diversity of human parechoviruses in Nizhny Novgorod].
    Golitsina LN; Zverev VV; Novikova NA; Fomina SG; Parfenova OV; Epifanova NV; Lukovnikova LB; Morozova OV; Ponomareva NV
    Vopr Virusol; 2013; 58(2):29-33. PubMed ID: 23785767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.